Neovacs has announced a €7.5m capital increase with three US institutional investors specialised in biotech investments. This capital increase will be carried out without preferential subscription rights. Neovacs will issue a total of 7.5m securities (30.5% of the shares of the company to date) at a price of one euro. Each security is composed of one ordinary share and one warrant. The warrant will be immediately detached from the share and will give the right to subscribe to 0.37732 of
01 Jul 2015
€7.5m capital increase
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
€7.5m capital increase
Neovacs SA (0W8U:LON) | 0 0 0.4% | Mkt Cap: 32.4m
- Published:
01 Jul 2015 -
Author:
Armelle Moulin -
Pages:
2
Neovacs has announced a €7.5m capital increase with three US institutional investors specialised in biotech investments. This capital increase will be carried out without preferential subscription rights. Neovacs will issue a total of 7.5m securities (30.5% of the shares of the company to date) at a price of one euro. Each security is composed of one ordinary share and one warrant. The warrant will be immediately detached from the share and will give the right to subscribe to 0.37732 of